Abstract Wound ointment (WO) contains active compositions that efficiently promote fracture healing by increasing the expression of Vascular Endothelial Growth Factor (VEGF). This study provides a systematic chemical and molecular characterization of WO, identifying its primary active compounds and demonstrating its therapeutic superiority in a rabbit model.
Introduction
Bone fracture healing is a complex biological sequence involving inflammation, callus formation, and eventual bone remodeling. While surgical intervention remains the standard of care, it carries inherent risks, particularly for elderly populations. Traditional Chinese Medicines (TCM), such as Wound Ointment (WO), have been utilized clinically for over 30 years to promote bone union. However, these treatments often lack the rigorous chemical and molecular characterization necessary for broader clinical acceptance. This study, published in Chinese Medicine, seeks to bridge this gap by identifying the specific chemical constituents of WO and evaluating its performance against a popular commercial benchmark, Yunnan Baiyao (YB), in a controlled animal model.
Methods
The research team employed a multi-disciplinary approach to evaluate the efficacy and mechanism of WO:
- Chemical Characterization: Liquid Chromatography-Mass Spectrometry (LC–MS) was used to perform qualitative and quantitative analysis of the ointment’s ingredients.
- Animal Study: 54 male New Zealand rabbits underwent surgery to create a radius fracture. They were divided into three groups: a saline control, a Yunnan Baiyao (YB) group, and the WO group.
- Evaluation Suite: Healing was tracked via radiography (X-ray and micro-CT), histology (HE staining), biochemical markers (Alkaline phosphatase assays), and molecular analysis (IHC, Western blot, and ELISA) to quantify VEGF expression at the fracture site.
Key Results
Identification of the "Active 12"
LC-MS analysis identified 12 primary active compositions within WO, including Asperosaponin VI, Naringin, and Emodin. Notably, Asperosaponin VI is known to accelerate the differentiation of bone marrow stem cells into bone-building osteoblasts, providing a chemical basis for the ointment's clinical success.
Enhanced Bone Remodeling and Volume
Radiographic analysis revealed that WO significantly accelerates the disappearance of the fracture line. By day 35, the fracture line in the WO group had almost entirely disappeared, whereas "ghosting" remained in the YB group. Micro-CT data at day 21 showed the WO group achieved a bone volume of 1.197 ± 0.066, significantly higher than the control (0.684 ± 0.043) and the YB group (0.942 ± 0.061).
Angiogenesis and the VEGF Surge
The study highlights that bone healing is heavily dependent on blood supply. WO significantly increased the expression of VEGF, a signal protein that stimulates the formation of new blood vessels (neovascularization). ELISA tests revealed that VEGF levels in the WO group peaked at nearly 3000 pg/mL by day 28, providing a massive biological stimulus for blood vessel growth compared to the other groups.
Serum Markers of Formation
Alkaline phosphatase (ALP) levels, a key marker for active bone formation, were highest in the WO group, peaking at day 28. This correlates with the observed increase in bone density and volume during the same period.
Discussion and Limitations
While the study demonstrates that WO is superior to standard benchmarks in the interim stages of healing, the authors acknowledge several limitations. The molecular focus was primarily on VEGF; other critical proteins like Bone Morphogenetic Protein 2 (BMP-2) and Type I collagen likely contribute to the process but were not measured. Additionally, the rabbit radius fracture is a "clean" experimental model that may not fully replicate the complexity of human fractures involving soft tissue damage or infection.
Future research should explore the effects of WO on a broader range of cytokines and move toward human clinical trials to validate these findings in a clinical setting. By pinpointing the upregulation of VEGF as a key mechanism, this study provides a scientific foundation for the continued use and development of WO in orthopedic medicine.
Summary updated